Browsing by Author Mitsios, J. V.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 8 to 22 of 22 < previous 
TitleAuthor(s)Issue date???itemlist.???
Highly constrained cyclic (S,S) -CXaaC- peptides as inhibitors of fibrinogen binding to plateletsKouki, A.; Mitsios, J. V.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Tselepis, A. D.; Tsikaris, V.; Tsoukatos, D. C.24-Nov-2015-
Human platelets secrete the plasma type of platelet-activating factor acetylhydrolase primarily associated with microparticlesMitsios, J. V.; Vini, M. P.; Stengel, D.; Ninio, E.; Tselepis, A. D.24-Nov-2015-
Inhibition of platelet activation and fibrinogen binding to alpha(IIb)beta(3) using synthetic peptide-analogues derived from the beta(3) subunit: A comparative studyTselepis, A. D.; Rodi, F. I.; Mitsios, J. V.; Stathopoulos, P.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Michalis, L. K.; Goudevenos, J. A.; Elisaf, M.; Tsoukatos, D.; Tsikaris, V.; Sideris, D. A.24-Nov-2015-
Inhibition of platelet activation by peptide analogs of the beta(3)-intracellular domain of platelet integrin alpha(IIb)beta(3) conjugated to the cell-penetrating peptide Tat(48-60)Dimitriou, A. A.; Stathopoulos, P.; Mitsios, J. V.; Sakarellos-Daitsiotis, M.; Goudevenos, J.; Tsikaris, V.; Tselepis, A. D.24-Nov-2015-
The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromesMitsios, J. V.; Papathanasiou, A. I.; Elisaf, M. S.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015-
Investigation of the role of adjacent amino acids to the 313-320 sequence of the alpha(IIb) subunit on platelet activation and fibrinogen binding to alpha(IIb)beta(3)Mitsios, J. V.; Stamos, G.; Rodis, F. I.; Tsironis, L. D.; Stanica, M. R.; Sakarellos, C.; Tsoukatos, D.; Tsikaris, V.; Tselepis, A. D.24-Nov-2015-
Lipoprotein(a) inhibits PAF-induced activation of human platelets in a manner independent of the endogenous PAF-acetylhydrolase activityTselepis, A.; Tsironis, L. D.; Mitsios, J. V.; Milionis, H. J.; Elisaf, M.24-Nov-2015-
Lp(a) inhibits PAF-induced activation of the platelet integrin alpha(IIb)beta(3) and fibrinogen bindingMitsios, J. V.; Tsironis, L. D.; Milionis, H. J.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Mapping the binding domains of the alpha(IIb) subunit - A study performed on the activated form of the platelet integrin alpha(IIb)beta(3)Biris, N.; Abatzis, M.; Mitsios, J. V.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Tsoukatos, D.; Tselepis, A. D.; Michalis, L.; Sideris, D.; Konidou, G.; Soteriadou, K.; Tsikaris, V.24-Nov-2015-
Mapping the binding domains of the alpha(IIb) subunit. A study performed on the activated form of the platelet integrin alpha(IIb)beta(3)Biris, N.; Abatzis, M.; Mitsios, J. V.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Tsoukatos, D.; Tselepis, A. D.; Michalis, L.; Sideris, D.; Konidou, G.; Soteriadou, K.; Tsikaris, V.24-Nov-2015-
Platelet derived microparticles inhibit Cu2+-induced LDL oxidationMitsios, J. V.; Lourida, E. S.; Papavasiliou, E. C.; Tselepis, A. D.24-Nov-2015-
Platelet-activating factor (PAF) and PAF-acetylhydrolase activity are secreted from human platelets mainly associated with platelet derived microparticlesMitsios, J. V.; Tsironis, L. D.; Tselepis, A. D.24-Nov-2015-
Platelet-derived microparticles inhibit the oxidative modification of LDL possibly through their phosphatidylserine and plasmalogen contentMitsios, J. V.; Tsironis, L. D.; Dimitriou, A. A.; Tselepis, A. D.24-Nov-2015-
Potential statin-clopidogrel interaction requires more study - ResponseMitsios, J. V.; Papathanasiou, A. I.; Rodis, F. I.; Elisaf, M.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015-
Reduced PAF-acetylhydrolase activity associated with Lp(a) in patients with coronary artery diseaseTsironis, L. D.; Katsouras, C. S.; Lourida, E. S.; Mitsios, J. V.; Goudevenos, J.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-